Shareholders' equity · 2016–2025
Bridgebio Pharma shareholders' equity
−$2.1B−$619M · FY2025
Bridgebio Pharma (BBIO) reported −$2.1B in shareholders' equity for fiscal 2025, −$619M from the year before.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | −$2.1B | −$619M | Open → |
| FY20242024-12-31 | −$1.5B | −$114M | Open → |
| FY20232023-12-31 | −$1.4B | −$99.6M | Open → |
| FY20222022-12-31 | −$1.3B | −$384M | Open → |
| FY20212021-12-31 | −$870M | −$928M | Open → |
| FY20202020-12-31 | $57.9M | −85.8% | Open → |
| FY20192019-12-31 | $408M | +29.7% | Open → |
| FY20182018-12-31 | $315M | +266.8% | Open → |
| FY20172017-12-31 | $85.9M | +476.6% | Open → |
| FY20162016-12-31 | $14.9M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Bridgebio Pharma shareholders' equity |url=https://companiesranked.com/en/company/bridgebio-pharma/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Bridgebio Pharma shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/bridgebio-pharma/shareholders-equityBibTeX
@misc{companiesranked-en-company-bridgebio-pharma-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Bridgebio Pharma shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/bridgebio-pharma/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001743881-26-000027 · August 10, 2026
{{cite web |title=Bridgebio Pharma shareholders' equity — 10-Q (0001743881-26-000027) |url=https://www.sec.gov/Archives/edgar/data/1743881/000174388126000027/bbio-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-10}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.